Iain D. Dukes, Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 12,000 shares at $8.65 ($104K) on 2018-12-18, disclosed to the SEC on 2018-12-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |